Key result
Antihypertensive therapy changes occur in ~75% of patients within one year, driving higher healthcare costs.
Why the study?
Patterns of antihypertensive drug modifications and their impact on health services costs during initial therapy were not well characterized.
Do different initial antihypertensive treatment regimens affect the likelihood of therapy modifications and health services costs in adults?
Observational
Do different initial antihypertensive treatment regimens affect the likelihood of therapy modifications and health services costs in adults?
Modifications to initial antihypertensive therapy are common and associated with increased health services costs, with fixed-dose combinations and two-drug regimens reducing the likelihood of certain modifications.
Answers are grounded in this paper and cite their sources.
Therapy modifications after antihypertensive initiation associate with higher costs; leaves open whether fixed-dose regimens improve persistence in prospective trials.
This study sought to identify patterns of antihypertensive drug modifications in initial drug therapy as well as to examine the effect of modifications on costs. The study population included adults who initiated antihypertensive drug therapy during 12 months of therapy. Approximately three-fourths of study participants had a change in therapy within the first 12 months of treatment. Discontinuation (57.1%) of antihypertensive drug treatment was the most prevalent modification type, followed by titrations (14.6%). Initiating treatment with fixed-dose combinations was associated with the lowest likelihood of a nondiscontinuation modification (12.5%); the use of 2 separate drugs was associated with the least likelihood of complete discontinuation (28.7%). The presence of therapy changes was associated with increased health services costs in the first 12 months of antihypertensive drug therapy. Clinicians and payers should be aware of the association between starting specific antihypertensive treatment regimens and the likelihood of changes in medication and changing costs.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2008) conducted an observational in Hypertension. Antihypertensive drug modifications was evaluated on Patterns of antihypertensive drug modifications and health services costs. Within 12 months of initiating antihypertensive therapy, approximately 75% of patients had a therapy change, most commonly discontinuation, which was associated with increased costs.
Synapse has enriched 10 related papers. Consider them for comparative context: